PER
Click for more information
3.57% 8.7¢ percheron therapeutics limited

For General Information, page-2762

  1. BoomCrashOffera
    720 Posts.
    lightbulb Created with Sketch. 210
    clock Created with Sketch.
    11/09/23
    10:23
    Post #: 69807238
    Not that it changes the point you made, but I think the PRV reduces the maximum FDA review time by 4 months rather than 6 months (i.e. review period from 10 months down to 6 months).
    Last edited by BoomCrashOffera: 11/09/23
    ANP Price at posting: 6.3¢ Sentiment: Hold Disclosure: Held
    Likes Created with Sketch. 6  Upvote
    lightbulb Created with Sketch.  Great analysis
    Stroke 3 Created with Sketch. Comments Created with Sketch. Reply

  2. Top Stories

 

Featured News

EMR Emerald expands underground resource by 105Koz at Cambodian gold mine Okvau
right-arrow Created with Sketch.
TLG Talga expands Prospectus Offer to $9M, banks $18.5M overall since end of financial year
right-arrow Created with Sketch.
NEWS Consumer Staples Shine Amid Retail Slump – Key Stocks to Watch
right-arrow Created with Sketch.
EBR EBR reaches review milestone for wireless cardiac pacing device
right-arrow Created with Sketch.
NEWS Week 35 Wrap: HotCopper’s top watched; ‘iron ore winter’ has started; Oz inflation @ 3.5% MoM; Harris fracking flip
right-arrow Created with Sketch.
NEWS Results wrap: Wesfarmers, Southern Cross Media, Qantas
right-arrow Created with Sketch.
watchlist Created with Sketch. Add PER (ASX) to my watchlist
(20min delay)
Last
8.7¢ 		Change
0.003(3.57%) 		Mkt cap ! $78.43M
Open High Low Value Volume
8.4¢ 8.7¢ 8.4¢ $72.99K 855.8K

Buyers (Bids)

No. Vol. Price($)
2 452608 8.4¢
 

Sellers (Offers)

Price($) Vol. No.
8.7¢ 398595 1
View Market Depth
Last trade - 16.10pm 30/08/2024 (20 minute delay) ?
PER (ASX) Chart
arrow-down-2 Created with Sketch. arrow-down-2 Created with Sketch.